Hepatic
ischemia-reperfusion (IR) injury is a severe pathophysiological
event during liver surgery or transplantation and could lead to liver
failure or even death. The energy supply of mitochondria plays an
essential role in preventing IR injury. Mitochondrial DNA (mtDNA)
is involved in maintaining the balance of energy by participating
in an oxidative phosphorylation process. However, the exact relationship
between IR and mtDNA remains unclear by reason of the lack of an accurate
real-time analysis method. Herein, we fabricated a mitochondria-targeting
fluorescent probe (mtDNA-BP) to explore mtDNA stability and supervise
the changes in mtDNA in IR liver. By virtue of pyridinium electropositivity
and suitable size, mtDNA-BP could accumulate in mitochondria and insert
into the mtDNA groove, which made mtDNA-BP fluoresce strongly. This
is attributed to the reduction of the intramolecular rotation energy
loss that is restricted by DNA. By in situ fluorescence imaging, we
observed in real time that mtDNA damage was aggravated by deteriorating
IR injury, so the ROS-mtDNA-mediated IR damage signal pathway was
speculated. Furthermore, on the basis of mtDNA-BP real-time response
capability for mtDNA, we established a drug-screening method for inhibiting
IR injury and found superior therapeutic performance of two potential
drugs: pioglitazone and salidroside. This work contributes to our
understanding of mtDNA-related disease and provides a new drug analysis
method.